Stories
Discovery
2021 Updates: Lilly's Global COVID-19 Response
View Story
2020 Updates: Lilly's Global COVID-19 Response
View Story
Lilly's COVID-19 Science Leads to a Second FDA Emergency Use Authorization
View Story
When the World Called for Help with COVID-19, We Were Ready
View Story
Dave Ricks Shares About Lilly's FDA Emergency Use Authorization for a Neutralizing Antibody
View Story
CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access
View Story
Lilly Creates Mobile Research Units to Reach Elderly Patients
View Story
How to Prevent the Next Pandemic: Antimicrobial Resistance
View Story
Testing for the Novel Coronavirus
View Story
Lilly Accelerates Cancer R&D with Speed and Precision
View Story